My research is focused on attaining a better understanding of the initiation, maintenance and progression of lymphoid tumors, and their response to immunochemotherapy toward improving current treatment strategies. In this effort, I employ tools from functional genomics, computational biology, molecular genetics and mouse models. I hope to apply this knowledge towards the design of clinical trials in the treatment of patients with lymphoma, leukemia, and myeloma.